CDC Recommends Moderna COVID-19 Vaccine (Spikevax) for Children and Adolescents Ages 6 through 17 Years
On June 23, 2022, CDC Director Rochelle P. Walensky, MD, MPH, endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation that Moderna’s COVID-19 vaccine (also known by its trade name, Spikevax) be administered as a vaccination option for children and adolescents ages 6 through 17 years. 

This CDC recommendation of Moderna’s COVID-19 Vaccine (Spikevax) for children and adolescents ages 6 through 17 years
  • Comes after a thorough review of the scientific evidence demonstrating safety and efficacy,
  • Supports using the vaccine among those ages 6 through 17 years,
  • Expands CDC’s already recommended use of Moderna’s COVID-19 (Spikevax) vaccine in children 6 months through 5 years, and adults 18 years and older,
  • Provides another vaccine option for children and adolescents ages 6 through 17 years, and
  • Reinforces the vaccine as an important tool in the pandemic by providing another vaccine option for children and adolescents ages 6 through 17 years.
Dr. Walensky said, “It is critical that we protect our children and teens from the complications of severe COVID-19 disease. Today, we have expanded the options available to families by recommending a second safe and effective vaccine for children ages 6 through 17 years. Vaccinating this age group can provide greater confidence to families that their children and adolescents participating in childcare, school, and other activities will have less risk for serious COVID-19 illness.”

Additional Resources for Healthcare Professionals
The Emergency Risk Communication Branch in the Division of Emergency Operations, Center for Preparedness and Response is responsible for the management of all COCA Products. 
For information about this update or other clinical issues, or to send your feedback, please contact us at
Clinician Outreach and Communication Activity—resources for healthcare providers
COCA RSS Feed—subscribe to be notified of conference calls, updates, and CDC guidance for health providers
Crisis & Emergency Risk Communication Training—training program that draws from lessons learned during public health emergencies, and incorporates best practices from the fields of risk and crisis communication
Health Alert Network—CDC's primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, and local public health practitioners; clinicians; and public health laboratories

CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

Links to non-federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organizations.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |  Unsubscribe